Constraining the Expression of Nicotinic Acetylcholine Receptors by Using Pentameric Constructs

Much of our understanding of ligand-gated ion channels comes from heterologous expression studies. However, this technique cannot produce receptors with a predetermined subunit composition for channels formed by several different subunits and cannot insert a single mutation copy if the subunit of in...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmacology Vol. 69; no. 2; pp. 558 - 563
Main Authors Groot-Kormelink, Paul J, Broadbent, Steven, Beato, Marco, Sivilotti, Lucia G
Format Journal Article
LanguageEnglish
Published United States American Society for Pharmacology and Experimental Therapeutics 01.02.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Much of our understanding of ligand-gated ion channels comes from heterologous expression studies. However, this technique cannot produce receptors with a predetermined subunit composition for channels formed by several different subunits and cannot insert a single mutation copy if the subunit of interest is present in several copies in the channel. Here, we describe a novel approach that overcomes these problems by expressing pentameric constructs, in which the code of the five subunits is linked (i.e., β4_β4_α3_β4_α3). This is the first time that a concatemer of the complete pentameric receptor has been expressed for channels in the cysteine-loop superfamily. The presence of the linker did not change the agonist or antagonist sensitivity of α3β4 nicotinic receptors. We show evidence that the expressed receptors were made up of α3 and β4 subunits in one pentameric fusion protein as designed in the construct. This approach can be applied to any nicotinic superfamily receptor to produce channels with a defined subunit arrangement and to introduce specific mutations at any desired location of the pentameric fusion protein.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0026-895X
1521-0111
DOI:10.1124/mol.105.019356